tradingkey.logo
tradingkey.logo
Pesquisar

Cibus Inc

CBUS
Adicionar à lista de desejos
1.310USD
-0.100-7.09%
Fechamento 05/15, 16:00ETCotações atrasadas em 15 min
99.99MValor de mercado
PerdaP/L TTM

Mais detalhes de Cibus Inc Empresa

Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.

Informações de Cibus Inc

Código da empresaCBUS
Nome da EmpresaCibus Inc
Data de listagemJul 20, 2017
CEOBeetham (Peter Ronald)
Número de funcionários157
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 20
Endereço6455 Nancy Ridge Drive
CidadeSAN DIEGO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92121
Telefone18584500008
Sitehttps://www.cibus.com/
Código da empresaCBUS
Data de listagemJul 20, 2017
CEOBeetham (Peter Ronald)

Executivos da empresa Cibus Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.96M
--
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
592.70K
+38.19%
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
139.88K
+27.17%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
85.47K
-35.32%
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
40.20K
--
Mr. Mark Finn
Mr. Mark Finn
Lead Independent Director
Lead Independent Director
--
--
Mr. Jean-Pierre Lehmann
Mr. Jean-Pierre Lehmann
Independent Director
Independent Director
--
--
Dr. Keith A. Walker, Ph.D.
Dr. Keith A. Walker, Ph.D.
Independent Director
Independent Director
--
--
Dr. Greg Gocal, Ph.D.
Dr. Greg Gocal, Ph.D.
Co-Founder, Executive Vice President, Chief Scientific Officer
Co-Founder, Executive Vice President, Chief Scientific Officer
--
--
Mr. Cornelis (Carlo) Broos
Mr. Cornelis (Carlo) Broos
Chief Financial Officer
Chief Financial Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.96M
--
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
592.70K
+38.19%
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
139.88K
+27.17%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
85.47K
-35.32%
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
40.20K
--
Mr. Mark Finn
Mr. Mark Finn
Lead Independent Director
Lead Independent Director
--
--

Detalhamento da receita

FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2023
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
United States
0.00
0.00%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: qui, 14 de mai
Atualizado em: qui, 14 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Riggs (Rory B)
19.61%
Fidelity Management & Research Company LLC
9.57%
Vanguard Capital Management, LLC
2.78%
JPL Investments SA
2.21%
Vantage Consulting Group, Inc.
1.50%
Outro
64.33%
Investidores
Investidores
Proporção
Riggs (Rory B)
19.61%
Fidelity Management & Research Company LLC
9.57%
Vanguard Capital Management, LLC
2.78%
JPL Investments SA
2.21%
Vantage Consulting Group, Inc.
1.50%
Outro
64.33%
Tipos de investidores
Investidores
Proporção
Individual Investor
22.51%
Investment Advisor
14.29%
Corporation
2.21%
Investment Advisor/Hedge Fund
2.17%
Hedge Fund
0.90%
Research Firm
0.15%
Family Office
0.13%
Bank and Trust
0.04%
Venture Capital
0.03%
Outro
57.55%

Participação acionária institucional

Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
162
12.20M
16.60%
-2.35M
2025Q4
155
11.44M
29.24%
--
2025Q3
160
11.44M
29.36%
-1.15M
2025Q2
160
12.59M
24.13%
+683.12K
2025Q1
154
11.90M
30.83%
+1.84M
2024Q4
150
9.30M
35.60%
+430.74K
2024Q3
137
8.87M
33.20%
+582.16K
2024Q2
125
8.28M
27.75%
+2.07M
2024Q1
106
6.21M
28.39%
+246.00K
2023Q4
96
5.70M
24.18%
+956.24K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Riggs (Rory B)
14.96M
19.64%
+333.33K
+2.28%
Jan 29, 2026
Fidelity Management & Research Company LLC
7.30M
9.58%
-43.10K
-0.59%
Dec 31, 2025
JPL Investments SA
1.67M
2.2%
-12.28K
-0.73%
Mar 24, 2025
Vantage Consulting Group, Inc.
1.14M
1.5%
--
--
Dec 31, 2025
Lehmann (Jean-Pierre Jules)
699.16K
0.92%
+666.67K
+2051.91%
Jan 29, 2026
Beetham (Peter Ronald)
382.44K
0.5%
--
--
Mar 24, 2025
Gocal (Gregory Francis William)
374.84K
0.49%
+60.00K
+19.06%
Mar 24, 2025
Prescott Group Capital Management, LLC
198.16K
0.26%
+198.16K
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
307.52K
0.4%
+25.37K
+8.99%
Dec 31, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Value ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
Proporção0.01%
iShares Russell 2000 Value ETF
Proporção0%
Global X Russell 2000 ETF
Proporção0%
Proshares Ultra Russell 2000
Proporção0%
ProShares UltraPro Russell2000
Proporção0%
ProShares Hedge Replication ETF
Proporção0%
iShares Core S&P Total U.S. Stock Market ETF
Proporção0%
iShares Russell 2000 ETF
Proporção0%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Jun 01, 2023
Merger
5→1
Apr 07, 2023
Merger
10→1
Data
Data ex-dividendo
Tipo
Proporção
Jun 01, 2023
Merger
5→1
Apr 07, 2023
Merger
10→1
KeyAI